1673-422X
2013 Issue 9
Proto-oncogene Bmi-1 and head and neck cancer
GAO Shan;WANG Ren-sheng
GAO Shan;WANG Ren-sheng
..............page:665-668
Progression of risk related genes in thyroid papillary carcinoma
JIANG Lie-hao;GE Ming-hua;LING Zhi-qiang
JIANG Lie-hao;GE Ming-hua;LING Zhi-qiang
..............page:671-674
Wnt/β-catenin signaling pathway and glioma
CHEN Meng-na;LIU Ting;GUO Geng
CHEN Meng-na;LIU Ting;GUO Geng
..............page:668-670
Serum thymidine kinase 1 and cancer
XU Wen-jing;LIU De-gan
XU Wen-jing;LIU De-gan
..............page:643-645
Lysyal oxidase propeptide and tumor
YANG Jie;ZHU Hong
YANG Jie;ZHU Hong
..............page:646-648
Separation of breast cancer stem cell and its heterogeneity
KONG Mian;LIN Yu;WANG Jun-ye;LI Bao-jiang
KONG Mian;LIN Yu;WANG Jun-ye;LI Bao-jiang
..............page:674-677
Reserch progress of nasopharyngeal carcinoma related gene
CHENG Hong-lei;WANG Ruo-yu
CHENG Hong-lei;WANG Ruo-yu
..............page:662-665
Expression of CXCR4 in breast cancer and the relationship between CXCR4 and Hedgehog signaling pathway
XU Shuang-fei;WANG Jie;ZHUANG Zhi-gang
XU Shuang-fei;WANG Jie;ZHUANG Zhi-gang
..............page:711-714
Expression and clinical significance of EphA8 in colon cancer
LU Xin-jun;LI Xiao
LU Xin-jun;LI Xiao
..............page:715-720
Multi-disciplinary and comprehensive treatment of colorectal cancer
XU Jing;SUN Xiu-hua;GAO Chong
XU Jing;SUN Xiu-hua;GAO Chong
..............page:699-702
Effects of anti-tumor drugs on myeloid-derived suppressor cells
WANG Tian;LIANG Xiao-hua
WANG Tian;LIANG Xiao-hua
..............page:655-658
Applications of molecular targeted drugs in hepatocellular carcinoma
SUN Hai-feng;RUAN Zhi-ping;YAO Yu
SUN Hai-feng;RUAN Zhi-ping;YAO Yu
..............page:695-698
Gastrointestinal malignancies and cardiovascular diseases
WANG Qian-qian;XU Chao
WANG Qian-qian;XU Chao
..............page:692-695
Advances in the treatment of aggressive non-Hodgkin's lymphoma
GU Jun-jiao;LIU Yan-yan
GU Jun-jiao;LIU Yan-yan
..............page:705-707
Expressions of MMP-2 and MMP-9 in esophageal cancer
WU Zhi;PAN Xiao-ling;ZHONG Jie
WU Zhi;PAN Xiao-ling;ZHONG Jie
..............page:708-711
Application of three-dimensional cell culture model in cancer research
WANG Jie-yu;FENG Wei-wei
WANG Jie-yu;FENG Wei-wei
..............page:659-661
Metabolomics in ovarian cancer
JIN Fu-jun;RAN Guang-han
JIN Fu-jun;RAN Guang-han
..............page:702-704
PTEN and gastric cancer
WANG Si-jia;LI Lian-hong
WANG Si-jia;LI Lian-hong
..............page:689-692
Chemokine CXCL12 and cancer
ZHAO Tai-cheng;BAI Ying
ZHAO Tai-cheng;BAI Ying
..............page:649-652
Stereotactic body radiotherapy in the treatment of early non-small cell lung cancer
XU Lu;LI Duo-jie
XU Lu;LI Duo-jie
..............page:684-686
..............page:648,677,720
Treatment of triple negative breast cancer
LIANG Jin-ping;ZHANG Xi-ping
LIANG Jin-ping;ZHANG Xi-ping
..............page:681-684
Molecular targeted therapy for breast cancer patients based on Notch signal transduction pathway
ZHANG Yong-qu;DOU Xiao-wei;ZHANG Guo-jun
ZHANG Yong-qu;DOU Xiao-wei;ZHANG Guo-jun
..............page:678-680
Advances of CpG island methylation phenotypes in gastric cancer
Lü Ping;LING Zhi-qiang
Lü Ping;LING Zhi-qiang
..............page:687-689
Hypoxia-inducible factor-1 and transforming growth factor-β in tumor
GAO Chao;FENG Xiang-ying
GAO Chao;FENG Xiang-ying
..............page:652-655